Orbeseal
Active substance
ATC code
Species
Cattle (dairy cow at drying-off).
Indications
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the veterinary medicinal product can be used on its own in dry cow management and mastitis control.
Dose to be administered and administration route
Intramammary use only.
Infuse the contents of one intramammary syringe of the veterinary medicinal product into each udder quarter immediately after the last milking of the lactation (at drying off.). Do not massage the teat or udder after infusion of the veterinary medicinal product.
Care must be taken not to introduce pathogens into the teat in order to reduce the risk of post-infusion mastitis.
It is essential that the teat is thoroughly cleaned and disinfected, with surgical spirit or alcohol-impregnated wipes. The teats should be wiped until the wipes are no longer visibly dirty. Teats should be allowed to dry prior to infusion.
Infuse aseptically and take care to avoid contamination of the syringe nozzle.
Following infusion it is advisable to use an appropriate teat dip or spray.
Under cold conditions the veterinary medicinal product may be warmed to room temperature in a warm environment, to aid syringeability.
Adverse reactions
Cattle (dairy cow at drying-off).
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Acute mastitis1. |
1Primarily due to poor infusion technique and lack of hygiene. Please refer to sections 4.5 and 4.9 regarding the importance of aseptic technique.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also ‘Contact details’ section of the package leaflet.
Similar products
Showing 2 of 2 results
Orbeseal
